JP2023504186A5 - - Google Patents
Info
- Publication number
- JP2023504186A5 JP2023504186A5 JP2022533064A JP2022533064A JP2023504186A5 JP 2023504186 A5 JP2023504186 A5 JP 2023504186A5 JP 2022533064 A JP2022533064 A JP 2022533064A JP 2022533064 A JP2022533064 A JP 2022533064A JP 2023504186 A5 JP2023504186 A5 JP 2023504186A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- construct
- construct according
- hhhk
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962945042P | 2019-12-06 | 2019-12-06 | |
| US62/945,042 | 2019-12-06 | ||
| PCT/US2020/063676 WO2021113851A2 (en) | 2019-12-06 | 2020-12-07 | Peptide docking vehicle for targeted nucleic acid delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023504186A JP2023504186A (ja) | 2023-02-01 |
| JP2023504186A5 true JP2023504186A5 (cg-RX-API-DMAC7.html) | 2024-01-10 |
Family
ID=76222046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533064A Pending JP2023504186A (ja) | 2019-12-06 | 2020-12-07 | 標的化された核酸送達のためのペプチドドッキング賦形剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12054714B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4069261A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023504186A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220115579A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114885604B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020398192A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022010883A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3160576A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL293589A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021113851A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202207211B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114716518A (zh) * | 2021-01-06 | 2022-07-08 | 圣诺制药公司 | 一种能够抑制pcsk9表达的分子构造及药物组合物 |
| CN117836006A (zh) * | 2021-08-04 | 2024-04-05 | 和博医药有限公司 | 用于递送治疗活性剂的配体缀合物 |
| US12673115B2 (en) * | 2021-08-11 | 2026-07-07 | Arizona Board Of Regents On Behalf Of Arizona State University | Nucleic acid-peptide-nucleic acid conjugate molecules and methods of making the same |
| WO2023049807A2 (en) * | 2021-09-22 | 2023-03-30 | Sirnaomics, Inc. | Improved methods for preparing nanoparticle compositions containing histidine-lysine copolymers |
| WO2026032280A1 (zh) * | 2024-08-06 | 2026-02-12 | 北京茵诺医药科技有限公司 | 寡核苷酸缀合物、含有该寡核苷酸缀合物的组合物及制备方法和用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1812016A4 (en) * | 2004-11-17 | 2010-07-14 | Univ Maryland | HIGH-BRANCHED HK-PEPTIDES AS EFFECTIVE CARRIER FROM SIRNA |
| US8575123B2 (en) * | 2008-04-11 | 2013-11-05 | Tekmira Pharmaceuticals Corporation | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| EP3373979A1 (en) * | 2015-11-12 | 2018-09-19 | Pfizer Inc | Tissue-specific genome engineering using crispr-cas9 |
| KR102775461B1 (ko) * | 2016-04-01 | 2025-02-28 | 어비디티 바이오사이언시스 인크. | 핵산-폴리펩타이드 조성물 및 이의 용도 |
| AU2017296195A1 (en) * | 2016-07-11 | 2019-01-24 | Translate Bio Ma, Inc. | Nucleic acid conjugates and uses thereof |
| EP3526328A4 (en) * | 2016-10-17 | 2020-05-27 | Apellis Pharmaceuticals, Inc. | COMBINATION THERAPY FOR C3 INHIBITION |
| JP7512207B2 (ja) * | 2018-05-24 | 2024-07-08 | サーナオミクス インコーポレイテッド | 核酸治療薬のための調節可能な共カップリングポリペプチドナノ粒子送達系の組成物および方法 |
-
2020
- 2020-12-07 AU AU2020398192A patent/AU2020398192A1/en not_active Abandoned
- 2020-12-07 BR BR112022010883A patent/BR112022010883A2/pt not_active IP Right Cessation
- 2020-12-07 US US17/114,443 patent/US12054714B2/en active Active
- 2020-12-07 CA CA3160576A patent/CA3160576A1/en active Pending
- 2020-12-07 CN CN202080072338.1A patent/CN114885604B/zh active Active
- 2020-12-07 KR KR1020227021748A patent/KR20220115579A/ko active Pending
- 2020-12-07 IL IL293589A patent/IL293589A/en unknown
- 2020-12-07 WO PCT/US2020/063676 patent/WO2021113851A2/en not_active Ceased
- 2020-12-07 JP JP2022533064A patent/JP2023504186A/ja active Pending
- 2020-12-07 EP EP20896972.5A patent/EP4069261A4/en not_active Withdrawn
-
2022
- 2022-06-29 ZA ZA2022/07211A patent/ZA202207211B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023011614A5 (cg-RX-API-DMAC7.html) | ||
| EP2611927B1 (en) | Novel single chemical entities and methods for delivery of oligonucleotides | |
| JP2021533199A5 (cg-RX-API-DMAC7.html) | ||
| JP2021507686A5 (cg-RX-API-DMAC7.html) | ||
| JP5583667B2 (ja) | 長時間作用型dnaデンドリマーおよびその方法 | |
| JP2023537798A5 (cg-RX-API-DMAC7.html) | ||
| JP2025106480A5 (cg-RX-API-DMAC7.html) | ||
| JP7291418B2 (ja) | Pcsk9を標的としたアンチセンス核酸 | |
| CN102686243B (zh) | 用于抗癌剂递送的聚合物系统 | |
| CN1211923A (zh) | 增强生物分子的细胞摄取的配体 | |
| EP2976109B1 (en) | Cellular delivery of dna intercalating agents | |
| JP2008512097A (ja) | アプタマー医薬品化学 | |
| TWI726844B (zh) | 胜肽載體上之多重寡核苷酸部分 | |
| CN104244987A (zh) | 新型寡核苷酸缀合物及其应用 | |
| CN114885604B (zh) | 用于靶向递送核酸的肽对接载体 | |
| JP2016513089A (ja) | 細胞への遺伝子送達のための機能性dnaデンドリマー | |
| JP2023172954A5 (cg-RX-API-DMAC7.html) | ||
| AU2004232848A2 (en) | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics | |
| JP2024533427A5 (cg-RX-API-DMAC7.html) | ||
| JP2023524812A5 (cg-RX-API-DMAC7.html) | ||
| CN115244064A (zh) | 治疗性分子的靶向递送 | |
| US20040072743A1 (en) | Pharmaceutical composition of modified pna molecules | |
| JP2024512783A (ja) | 核酸の自己組織化媒介adc薬の構築方法および適用 | |
| TW202218687A (zh) | 骨骼肌遞送載體及其使用方法 | |
| Sarkar et al. | Recent developments in the delivery of peptide nucleic acids (PNAs) |